IL-10 and IL-10 receptor defects in humans

被引：197

作者：

Glocker, Erik-Oliver ^{[1
]}

Kotlarz, Daniel ^{[2
]}

Klein, Christoph ^{[2
]}

Shah, Neil ^{[3
]}

Grimbacher, Bodo ^{[4
,5
]}

机构：

[1] Univ Hosp Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany

[2] Univ Munich, Dr von Hauner Childrens Hosp, Dept Pediat, Munich, Germany

[3] UCL, Great Ormond St Hosp, Dept Paediat Gastroenterol, London, England

[4] UCL, Sch Med, Dept Immunol, London W1N 8AA, England

[5] Univ Hosp Freiburg, Ctr Chron Immune Deficiency, Freiburg, Germany

来源：

YEAR IN HUMAN AND MEDICAL GENETICS: INBORN ERRORS OF IMMUNITY II | 2011年 / 1246卷

关键词：

IL-10; receptor; mutation; STAT3; inflammatory bowel disease; INFLAMMATORY-BOWEL-DISEASE; REGULATORY T-CELLS; X-LINKED SYNDROME; INTERLEUKIN-10; RECEPTOR; IMMUNE DYSREGULATION; ULCERATIVE-COLITIS; EPITHELIAL-CELLS; CROHNS-DISEASE; HOST-DEFENSE; POLYENDOCRINOPATHY;

D O I：

10.1111/j.1749-6632.2011.06339.x

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), is chronic in nature and is characterized by abdominal pain, diarrhea, bleeding, and malabsorption. It is considered a complex multigenic and multifactorial disorder that results from disturbed interactions between the immune system and commensal bacteria of the gut. Recent work has demonstrated that IBD with an early-onset within the first months of life can be monogenic: mutations in IL-10 or its receptor lead to a loss of IL-10 function and cause severe intractable enterocolitis in infants and small children. Both IL-10 and IL-10 receptor deficiency can be successfully treated by hematopoietic stem cell transplantation.

引用

页码：102 / 107

页数：6

共 50 条

[41] A Gly15Arg mutation in the interleukin-10 gene reduces secretion of interleukin-10 in Crohn disease [J].

van der Linde, K ;

Boor, PPC ;

Sandkuijl, LA ;

Meijssen, MAC ;

Savelkoul, HFJ ;

Wilson, JHP ;

de Rooij, FWM .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (06) :611-617

[42] The Genetics of Crohn's Disease [J].

Van Limbergen, Johan ;

Wilson, David C. ;

Satsangi, Jack .

ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, 2009, 10 :89-116

[43] Interleukin-10 suppression of myeloid cell activation - a continuing puzzle [J].

Williams, LM ;

Ricchetti, G ;

Sarma, U ;

Smallie, T ;

Foxwell, BMJ .

IMMUNOLOGY, 2004, 113 (03) :281-292

[44] IL-22 increases the innate immunity of tissues [J].

Wolk, K ;

Kunz, S ;

Witte, E ;

Friedrich, M ;

Asadullah, K ;

Sabat, R .

IMMUNITY, 2004, 21 (02) :241-254

[45] Interleukin-22: A novel T- and NK-cell derived cytokine that regulates the biology of tissue cells [J].

Wolk, Kerstin ;

Sabat, Robert .

CYTOKINE & GROWTH FACTOR REVIEWS, 2006, 17 (05) :367-380

[46] IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes:: a potential role in psoriasis [J].

Wolk, Kerstin ;

Witte, Ellen ;

Wallace, Elizabeth ;

Doecke, Wolf-Dietrich ;

Kunz, Stefanie ;

Asadullah, Khusru ;

Volk, Hans-Dieter ;

Sterry, Wolfram ;

Sabat, Robert .

EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (05) :1309-1323

[47] Unravelling the pathogenesis of inflammatory bowel disease [J].

Xavier, R. J. ;

Podolsky, D. K. .

NATURE, 2007, 448 (7152) :427-434

[48] Innate and Adaptive Interleukin-22 Protects Mice from Inflammatory Bowel Disease [J].

Zenewicz, Lauren A. ;

Yancopoulos, George D. ;

Valenzuela, David M. ;

Murphy, Andrew J. ;

Stevens, Sean ;

Flavell, Richard A. .

IMMUNITY, 2008, 29 (06) :947-957

[49] Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens [J].

Zheng, Yan ;

Valdez, Patricia A. ;

Danilenko, Dimitry M. ;

Hu, Yan ;

Sa, Susan M. ;

Gong, Qian ;

Abbas, Alexander R. ;

Modrusan, Zora ;

Ghilardi, Nico ;

de Sauvage, Frederic J. ;

Ouyang, Wenjun .

NATURE MEDICINE, 2008, 14 (03) :282-289

[50] FOXP3: Of mice and men [J].

Ziegler, Steven F. .

ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 :209-226

← 1 2 3 4 5 →